{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreifjsrf4kj7zf3qtzgjfzrlqo7g5ubksjigsogqfgipvu6nndnoxgm",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mn24s6kn2ox2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreihs4yniv5gslv4xxwpwazmdqvpsj3sble4olz6hvbzdguafle3ihy"
    },
    "mimeType": "image/jpeg",
    "size": 123080
  },
  "path": "/pharmalot/2026/05/29/pharmalittle-were-reading-about-replimune-drug-getting-third-try-at-fda-approval-a-pfizer-deal-in-china-and-more/?utm_campaign=rss",
  "publishedAt": "2026-05-29T13:34:37.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Pharmalot",
    "Uncategorized",
    "pharmalittle",
    "STAT+"
  ],
  "textContent": "Pharma updates from the Pharmalot campus via the Pharmalittle newsletter",
  "title": "STAT+: Pharmalittle: We’re reading about Replimune drug getting third try at FDA approval, a Pfizer deal in China, and more",
  "updatedAt": "2026-05-29T13:34:41.000Z"
}